Immune Responses to H5N1 Vaccine With and Without MF59 Adjuvant
Conditions: Influenza; HealthyInterventions: Biological: H5N1 vaccine plus MF59 adjuvant; Biological: H5N1 vaccine without adjuvantSponsors: National Heart, Lung, and Blood Institute (NHLBI); Center for Human Immunology, Autoimmunity and Inflammation; National Institutes of Health Clinical Center (CC)Completed - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2012 Category: Research Source Type: clinical trials
H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: InfluenzaInterventions: Biological: H5N1 Vaccine; Drug: ASO3 AdjuvantSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials
H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: InfluenzaInterventions: Biological: H5N1 Vaccine; Drug: ASO3 AdjuvantSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials
H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: InfluenzaInterventions: Biological: H5N1 Vaccine; Drug: ASO3 AdjuvantSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials